Heterologous T cell immunity in severe hepatitis C virus infection
about
Defining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virusDengue virus pathogenesis: an integrated viewMutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to manProtective Efficacy of Cross-Reactive CD8+ T Cells Recognising Mutant Viral Epitopes Depends on Peptide-MHC-I Structural Interactions and T Cell Activation ThresholdDisparate Epitopes Mediating Protective Heterologous Immunity to Unrelated Viruses Share Peptide-MHC Structural Features Recognized by Cross-Reactive T CellsLack of heterologous cross-reactivity towards HLA-A*02:01 restricted viral epitopes is underpinned by distinct αβT cell receptor signaturesAdaptive immune responses in acute and chronic hepatitis C virus infectionPC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.CD4+ and CD8+ T-cell immunity to Dengue - lessons for the study of Zika virus.Anti-IFN-γ and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza A-specific memory T cellsCD8(+) T-Cell Responses in Acute Hepatitis C Virus Infection.Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent mannerEvolution of the antigen-specific CD8+ TCR repertoire across the life span: evidence for clonal homogenization of the old TCR repertoire.Heterologous immunity between virusesCross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosisHeterologous immunity: immunopathology, autoimmunity and protection during viral infections.Diversity of the CD8+ T cell repertoire elicited against an immunodominant epitope does not depend on the context of infection.Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope.The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients.Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses.Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity.Two distinct functional patterns of hepatitis C Virus (HCV)-specific T cell responses in seronegative, aviremic patientsTetramer enrichment reveals the presence of phenotypically diverse hepatitis C virus-specific CD8+ T cells in chronic infection.Vaccination and heterologous immunity: educating the immune systemCD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections.Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3.Why do adaptive immune responses cross-react?Private aspects of heterologous immunity.Selective expansion of high functional avidity memory CD8 T cell clonotypes during hepatitis C virus reinfection and clearanceThe expanding realm of heterologous immunity: friend or foe?Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjectsProtective immunity against hepatitis C virus infection.Conflicting selection pressures target the NS3 protein in hepatitis C virus genotypes 1a and 1b.Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity.Cross-reactivity of T cells and its role in the immune systemTranscriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.Terminal deoxynucleotidyltransferase is required for the establishment of private virus-specific CD8+ TCR repertoires and facilitates optimal CTL responses.Broad cross-reactive TCR repertoires recognizing dissimilar Epstein-Barr and influenza A virus epitopes.CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.
P2860
Q24645078-8A2B27DD-0EE9-4382-901D-920A4E0402B2Q24645380-F6AA7A6E-6212-46C4-B7D0-BB0E3085C323Q27485215-FBDB960E-538D-4DE7-AC3F-57524DFD13D9Q27664060-C0236441-7F63-4E8C-BFD7-DE2D912AAC3AQ27680365-C6E7BC18-6B5F-4D95-AC20-3E741CD43B9CQ27728085-758535D2-9E07-4AC0-8430-26267C43E72BQ29619722-4C772FA7-A49B-4805-95EF-300F1EB098ACQ30353758-8A4014C5-AD95-41A5-BC11-CFB3F9E6121BQ30394327-02878585-9BC5-47EB-B36E-C52F17676443Q30427198-4B49D958-E622-447D-9618-EAC6389CEFF1Q33718778-2255F9F8-E8B1-46D3-8B3B-781762EE64D5Q33822643-9E6AB4DE-3DCB-409A-BD3D-074250857D8AQ33993575-A34365ED-BDA4-45A7-ACD3-62ED9ED53092Q34051846-E6441F69-95D9-456E-8C1B-65F3F785CC94Q34147153-F5A31C5F-BC8E-4B45-A971-7A3B72944B8DQ34159981-BCB46CAE-386F-475F-82A7-669054AE8658Q34165211-57AAA4BD-4D0E-442F-96C2-92B63F5F2EA8Q34246886-C08A11F7-5C8D-4FCF-82F9-54FCD827D8F6Q34288498-6F445EE9-26A4-4DA5-83BA-4623475F98F1Q34453827-34ACBF34-B440-4130-85D8-AB818504CAFDQ34457915-25BBAEA3-9F7B-4E23-99C4-1049449CCF80Q34537506-64456CC6-F77B-4CE0-8A7E-2EB2882322A8Q34701250-AF18F325-38CC-49CC-848C-8B01BC4F44DEQ34992581-BCF877C0-05AA-42FE-B422-02E630B82D49Q35152750-3335F41A-FEE3-4D02-9F36-B7FFB109776AQ35660783-712756CF-79EB-48E5-92FB-ACD9461F5808Q35960524-C1E2CB42-D112-491C-A321-CD866EEAFAA2Q35960780-378DBE14-5BC4-4801-8AEC-FC86D82648FBQ36064461-81EEE338-F315-453A-9561-DCFC77E91FFCQ36266416-69C11465-37E4-4302-A210-779D1CD82A1CQ36379481-6EB6F2FC-AE6F-41AE-B342-23EF02DE2E17Q36402863-414197CD-ED13-4DD8-B0EA-AD57FCC5586AQ36410459-9120B24D-97AF-4F4D-8DB7-F64F58289B4CQ36485567-3C4C6CE2-A607-4295-8D4D-401351F84226Q36528984-F27F7FE6-3029-4662-9261-8B64050826EFQ36678774-7F0F8EFD-C6BF-41FA-B965-9952840628DFQ36925951-99B03E6D-906B-4A57-B919-FCBA1EA9D803Q37001455-5F0A76E3-BC44-4539-BD1C-6D3BF270D06FQ37082145-5DD56D2A-F0E1-4FBA-A83F-CF2DF2B5770DQ37145296-B3B55F2C-8720-4132-9603-A7549156EC63
P2860
Heterologous T cell immunity in severe hepatitis C virus infection
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Heterologous T cell immunity in severe hepatitis C virus infection
@ast
Heterologous T cell immunity in severe hepatitis C virus infection
@en
Heterologous T cell immunity in severe hepatitis C virus infection
@nl
type
label
Heterologous T cell immunity in severe hepatitis C virus infection
@ast
Heterologous T cell immunity in severe hepatitis C virus infection
@en
Heterologous T cell immunity in severe hepatitis C virus infection
@nl
prefLabel
Heterologous T cell immunity in severe hepatitis C virus infection
@ast
Heterologous T cell immunity in severe hepatitis C virus infection
@en
Heterologous T cell immunity in severe hepatitis C virus infection
@nl
P2093
P2860
P50
P356
P1476
Heterologous T cell immunity in severe hepatitis C virus infection
@en
P2093
Barbara Amadei
Massimo Pilli
Paola Fisicaro
Simona Urbani
P2860
P304
P356
10.1084/JEM.20041058
P407
P577
2005-03-07T00:00:00Z